Log In
BCIQ
Print this Print this
 

LAU-7b

  Manage Alerts
Collapse Summary General Information
Company Laurent Pharmaceuticals Inc.
DescriptionOral formulation of fenretinide, a synthetic retinoid
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today